The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(2-(3-(1-cyclopropyl-6-methyl-2-oxo-1,2-dihydropyridin-4-yloxy)azetidin-1-yl)-2-oxoethyl)-5,6-dimethylpyrimidin-4(3H)-one ID: ALA4515017
PubChem CID: 91814915
Max Phase: Preclinical
Molecular Formula: C20H24N4O4
Molecular Weight: 384.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ncn(CC(=O)N2CC(Oc3cc(C)n(C4CC4)c(=O)c3)C2)c(=O)c1C
Standard InChI: InChI=1S/C20H24N4O4/c1-12-6-16(7-18(25)24(12)15-4-5-15)28-17-8-22(9-17)19(26)10-23-11-21-14(3)13(2)20(23)27/h6-7,11,15,17H,4-5,8-10H2,1-3H3
Standard InChI Key: FOHSBRLNGVNZLV-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
2.4790 -3.2192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4779 -4.0387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1859 -4.4477 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8956 -4.0383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8928 -3.2156 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1842 -2.8103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5989 -2.8043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3082 -3.2103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0143 -2.7990 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8034 -3.0084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0119 -2.2183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2218 -2.0097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7181 -1.8070 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4273 -2.2129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4281 -3.0305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1365 -3.4363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8437 -3.0250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8380 -2.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1290 -1.8014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3113 -4.0275 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7699 -4.4468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7712 -2.8108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1817 -1.9932 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1392 -4.2535 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.5427 -1.7898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5536 -3.4297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9658 -4.1353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3708 -3.4255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 9 1 0
11 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 14 1 0
8 20 2 0
2 21 1 0
1 22 1 0
6 23 2 0
16 24 2 0
18 25 1 0
27 26 1 0
28 27 1 0
26 28 1 0
17 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 384.44Molecular Weight (Monoisotopic): 384.1798AlogP: 0.95#Rotatable Bonds: 5Polar Surface Area: 86.43Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.76CX LogP: -0.28CX LogD: -0.28Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.77Np Likeness Score: -1.08
References 1. Zhou Y, Tao P, Wang M, Xu P, Lu W, Lei P, You Q.. (2019) Development of novel human lactate dehydrogenase A inhibitors: High-throughput screening, synthesis, and biological evaluations., 177 [PMID:31129449 ] [10.1016/j.ejmech.2019.05.033 ]